-transparent.png){kind=logo}
Naloxone HCl (0.8 mg intravenously; n=9) or levallorphan tartrate (0.25 mg subcutaneously; n=5) had no effect on basal prolactin or growth hormone secretion in normal men. Neither narcotic antagonist inhibited the growth hormone secretory response to apomorphine HCl (0.75 mg subcutaneously). These findings suggest that narcotic antagonists do not block dopamine receptors in the hypothalamic-pituitary axis in man and that if these agents have antischizophrenic properties then these are not mediated by dopamine receptor blockade.
Related Publications
S Lal, and
N P Nair, and
P Cervantes, and
J Pulman, and
H Guyda
February 1981,
Experientia,
S Lal, and
N P Nair, and
P Cervantes, and
J Pulman, and
H Guyda
August 1983,
Journal of clinical psychopharmacology,
S Lal, and
N P Nair, and
P Cervantes, and
J Pulman, and
H Guyda
January 1980,
Postgraduate medical journal,
S Lal, and
N P Nair, and
P Cervantes, and
J Pulman, and
H Guyda
January 1984,
Panminerva medica,
S Lal, and
N P Nair, and
P Cervantes, and
J Pulman, and
H Guyda
November 1973,
The Journal of clinical endocrinology and metabolism,
S Lal, and
N P Nair, and
P Cervantes, and
J Pulman, and
H Guyda
September 1979,
Psychopharmacology,
S Lal, and
N P Nair, and
P Cervantes, and
J Pulman, and
H Guyda
September 1972,
Lancet (London, England),
S Lal, and
N P Nair, and
P Cervantes, and
J Pulman, and
H Guyda
May 1986,
Journal of animal science,
S Lal, and
N P Nair, and
P Cervantes, and
J Pulman, and
H Guyda
April 1977,
The Journal of clinical endocrinology and metabolism,
S Lal, and
N P Nair, and
P Cervantes, and
J Pulman, and
H Guyda
May 1979,
Brain research,
